Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis

Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis

Abstract Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for the treatment of diabetic wound healing. The present study aimed to investigate the effect of exosomes derived...

Full description

Bibliographic Details
Main Authors: Yiqiang Hu, Ranyang Tao, Lang Chen, Yuan Xiong, Hang Xue, Liangcong Hu, Chenchen Yan, Xudong Xie, Ze Lin, Adriana C. Panayi, Bobin Mi, Guohui Liu
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Journal of Nanobiotechnology
Subjects:
Exosomes
Mesenchymal stem cells
Pioglitazone
Diabetic wound
Angiogenesis
Online Access:https://doi.org/10.1186/s12951-021-00894-5

Internet

https://doi.org/10.1186/s12951-021-00894-5

Similar Items